3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
CNS
2
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Classical hematology
1
Conditions
Prostatic Neoplasms
5032
Carcinoma, Renal Cell
1579
Urinary Bladder Neoplasms
1281
Kidney Neoplasms
725
Breast Neoplasms
644
Neoplasms
633
Carcinoma, Transitional Cell
493
Carcinoma, Non-Small-Cell Lung
470
Neoplasm Metastasis
469
Melanoma
423
Ovarian Neoplasms
403
Colorectal Neoplasms
375
Lung Neoplasms
334
Pancreatic Neoplasms
263
Sarcoma
233
Stomach Neoplasms
227
Uterine Cervical Neoplasms
226
Testicular Neoplasms
216
Non-Muscle Invasive Bladder Neoplasms
216
Head and Neck Neoplasms
193
Squamous Cell Carcinoma of Head and Neck
189
Carcinoma, Hepatocellular
170
Endometrial Neoplasms
167
Colonic Neoplasms
167
Esophageal Neoplasms
165
Wilms Tumor
159
Recurrence
131
Triple Negative Breast Neoplasms
130
Small Cell Lung Carcinoma
127
Neuroblastoma
127
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Amyotrophic Lateral Sclerosis
×
Genitourinary
×
Clear all
NCT03516994
2024-05-16
EQUALACP
Duke University
Phase NA
Completed
790 enrolled